Shares of Castle Biosciences Inc (NASDAQ:CSTL) rose 7.8% after the company announced that its DecisionDx-Melanoma test has ...

Some experts believe a technological tipping point is imminent, if not already here, but adoption of point-of-care MDx has ...

The Uppsala University spinout aims to use its SuperRCA mutation detection technology for applications including molecular residual disease monitoring.